NASDAQ:CVET - Covetrus Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$34.78 -1.28 (-3.55 %)
(As of 03/24/2019 11:35 AM ET)
Previous Close$34.78
Today's Range$34.71 - $36.61
52-Week Range$32.00 - $43.83
Volume720,287 shs
Average Volume1.49 million shs
Market Capitalization$3.87 billion
P/E RatioN/A
Dividend YieldN/A
Covetrus, Inc. operates as an animal-health technology and services company. The company engages in the distribution of pharmaceuticals, nutrition products, consumable products, diagnostic tests, small and large equipment, laboratory products, surgical products, and others. It also develops, sells, and distributes practice management software systems and computer hardware for animal health customers, as well as offers software support, data driven applications, training and education, client communication services, and value-added services. In addition, the company operates technology platform that encompasses and integrates the functionality of pharmacy service, and prescription and inventory management in a single, secure, and regulatory-compliant system. It serves animal health practices and clinics in the companion animal and equine markets in North America, Europe, and Australasia. Covetrus, Inc. is headquartered in Portland, Maine.

Receive CVET News and Ratings via Email

Sign-up to receive the latest news and ratings for CVET and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Drug stores & proprietary stores
SectorComputer and Technology
Current SymbolNASDAQ:CVET



Sales & Book Value

Annual SalesN/A



Market Cap$3.87 billion
Next Earnings DateN/A
OptionableNot Optionable

Covetrus (NASDAQ:CVET) Frequently Asked Questions

What is Covetrus' stock symbol?

Covetrus trades on the NASDAQ under the ticker symbol "CVET."

What price target have analysts set for CVET?

3 equities research analysts have issued 12 month target prices for Covetrus' stock. Their predictions range from $45.00 to $45.00. On average, they anticipate Covetrus' stock price to reach $45.00 in the next year. This suggests a possible upside of 29.4% from the stock's current price. View Analyst Price Targets for Covetrus.

What is the consensus analysts' recommendation for Covetrus?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Covetrus in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Covetrus.

Has Covetrus been receiving favorable news coverage?

Media headlines about CVET stock have trended positive recently, InfoTrie Sentiment Analysis reports. InfoTrie identifies negative and positive media coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Covetrus earned a news sentiment score of 2.1 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 1.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the next several days.

Are investors shorting Covetrus?

Covetrus saw a increase in short interest during the month of February. As of February 15th, there was short interest totalling 5,275,730 shares, an increase of ∞ from the January 31st total of 0 shares. Based on an average daily trading volume, of 3,967,026 shares, the days-to-cover ratio is currently 1.3 days. Approximately 5.5% of the shares of the company are short sold. View Covetrus' Current Options Chain.

Who are some of Covetrus' key competitors?

What other stocks do shareholders of Covetrus own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Covetrus investors own include IMPINJ (PI), Western Digital (WDC), Gilead Sciences (GILD), Walt Disney (DIS), BOX (BOX), NIO (NIO), Rite Aid (RAD), FANUC LTD JAPAN/ADR (FANUY), Celgene (CELG) and Micron Technology (MU).

Who are Covetrus' key executives?

Covetrus' management team includes the folowing people:
  • Mr. Benjamin J. Shaw, Pres, CEO & Director (Age 40)
  • Ms. Christine T. Komola, EVP & CFO (Age 51)
  • Ms. Erin Powers Brennan, Sr. VP, Gen. Counsel & Sec. (Age 48)
  • Mr. James Edward Young, Sr. VP & Chief HR Officer (Age 60)
  • Mr. Russell Cooke, Sr. VP & Operational CFO (Age 53)

How do I buy shares of Covetrus?

Shares of CVET can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Covetrus' stock price today?

One share of CVET stock can currently be purchased for approximately $34.78.

How big of a company is Covetrus?

Covetrus has a market capitalization of $3.87 billion. Covetrus employs 5,000 workers across the globe.

How can I contact Covetrus?

Covetrus' mailing address is 7 Custom House Street, Portland ME, 04101. The company can be reached via phone at 888-280-2221.

MarketBeat Community Rating for Covetrus (NASDAQ CVET)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  21 (Vote Outperform)
Underperform Votes:  23 (Vote Underperform)
Total Votes:  44
MarketBeat's community ratings are surveys of what our community members think about Covetrus and other stocks. Vote "Outperform" if you believe CVET will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CVET will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/24/2019 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel